Johnn Lavis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr. Kirsty Short, a virologist and senior lecturer at “Recent phase 2/3 data from both Novavax and Johnson & Johnson suggest reduced protection against the South African variant,” Dr. Short reports. “The Oxford/AstraZeneca vaccine group also released data suggesting its vaccine offers only minimal protection against mild-moderate disease caused by this variant.” “It’s important to recognize ‘reduced protection’ doesn’t mean no protection at all, and that data are still emerging” and “What’s more, numerous vaccine manufacturers are now investigating whether tweaks to ...

Vaccine Equity Is Crucial to End the COVID-19 Pandemic — But It Won't Be Enough The pandemic cannot end until world leaders develop a global strategy to suppress COVID-19 variants. April 7, 2021 By Susan Michie, Chris Bullen, Jeffrey V. Lazarus, John N. Lavis, John Thwaites, Liam Smith, Salim Abdool Karim, and Yanis Ben Amor At the end of 2020, there was a strong hope that high levels of vaccination would see humanity finally gain the upper hand over SARS-CoV-2, the virus that causes COVID-19. In an ideal scenario, the virus would then be contained at very low levels without fur...

Covid-19 ‘variants of concern’ have changed the game – and vaccines alone may not be enough Members of the Lancet Covid-19 Commission Taskforce on Public Health have called for urgent action in response to the new variants. Many countries lack the capacity to track emerging variants via genomic surveillance. | Christophe Archambault / AFP At the end of 2020, there was a strong hope that high levels of vaccination would see humanity finally gain the upper hand over SARS-CoV-2, the virus that causes Covid-19. In an ideal scenario, the virus would then be contained at ve...

Michael Ciaglo/Getty Images The emergence of new Covid-19 variants has changed the game, and a successful global rollout of current vaccines by itself is no longer a guarantee of victory, writes  Susan Michie, Chris Bullen, Jeffrey V Lazarus, John N. Lavis, John Thwaites, Liam Smith, Salim Abdool Karim and Yanis Ben Amor. At the end of 2020, there was a strong hope that high levels of vaccination would see humanity finally gain the upper hand over SARS-CoV-2, the virus that causes Covid-19. In an ideal scenario, the virus would then be contained at very low levels without further societal d...

New Covid-19 variants have changed the game. Will vaccines be enough? By The Conversation Share By Susan Michie, Chris Bullen, Jeffrey V Lazarus, John N. Lavis, John Thwaites, Liam Smith, Salim Abdool Karim and Yanis Ben Amor At the end of 2020, there was a strong hope that high levels of vaccination would see humanity finally gain the upper hand over SARS-CoV-2, the virus that causes Covid-19. In an ideal scenario, the virus would then be contained at very low levels without further societal disruption or significant numbers of deaths. But since then, new “variants of concern” have...